在眼睛中调节TTR基因表达,使用修改的双重RNAs
Jiaxin Hu1, Xin Gong2, Jayanta Kundu3
1UT Southwestern Medical Center, Departments of Pharmacology and Biochemistry, Dallas TX 75390, USA.
脂质修饰的短干扰RNAs (siRNAs) 通过静脉内注射在眼睛中有效地抑制过敏素 (TTR) 基因表达. 这种方法为治疗眼睛TTR粉样性粉症提供了一个有前途的策略.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 药物运输 药物运输 药物运输
背景情况:
- 小干扰RNAs (siRNAs) 已被确立用于肝脏基因沉默.
- 晶氨基粉症 (TTR) 影响眼睛,需要对眼睛基因表达进行控制.
- 系统性抗TTR siRNAs治疗肝脏TTR表达,但不治疗眼部表现.
研究的目的:
- 为了研究脂质修饰siRNAs抑制眼睛TTR基因表达的疗效.
- 评估内注射作为眼部RNA干扰 (RNAi) 的输送方法.
主要方法:
- 局部静脉注射 (IVT) C5和2'-O结合脂质修饰siRNAs在盐水中的注射.
- 在眼组织中对TTR基因表达抑制的评估.
- 与GalNAc修饰的抗dsRNAs进行比较.
主要成果:
- 在IVT给药后,脂质修饰的siRNAs在眼睛中成功抑制了TTR基因表达.
- 脂质链长度和可访问性与体内静音效果相关.
- GalNAc修饰的siRNAs显示TTR抑制,但具有较低的强度.
结论:
- 通过IVT注射输送的脂质修饰siRNAs有效抑制眼球TTR表达.
- 这一策略有可能用于治疗眼睛TTR粉样性粉症.
- 脂类-siRNA结合体代表了用于眼部药物发现的多功能平台.
更多相关视频
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
10:59Use of Label-free Optical Biosensors to Detect Modulation of Potassium Channels by G-protein Coupled Receptors
Published on: February 10, 2014
相关概念视频
Regulation of Metabolism
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Allosteric Regulation
Regulation of Hormone Secretion
Humoral...
